Atlanta Braves-C
BATRK
51.96
-0.45
-0.86%
Atlanta Braves-C
US · BATRK
#2415 by market cap
Listed 1970
51.96
-0.45
-0.86%
Live - 5344 symbols - heartbeat 209s ago
· 2026-10-07 19:54
After-hours
51.96
0.00%
- Market cap
- 3.33B
- P/E (TTM)i
- -51.96
- P/Bi
- 6.48
- EPSi
- -0.37
- Div yieldi
- 0.00%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on BATRK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.66, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +10.52% YoY
Margins
- Gross margin
- 30.19%
- Operating margin
- 2.27%
- Net margin
- -3.19%
Key ratios & quality
- Enterprise valuei
- 3.97B
- Altman Z-Scorei
- 1.66
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 442.00M | 476.00M | 178.00M | 568.00M | 588.56M | 640.67M | 662.75M | 732.49M |
| Gross profit | -- | -- | -- | -- | 152.06M | 149.44M | 148.84M | 221.14M |
| Selling & admin expenses | 97.00M | 100.00M | 67.00M | 99.00M | 105.51M | 124.90M | 125.68M | 128.90M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.00M | -39.00M | -128.00M | 20.00M | -25.15M | -46.44M | -39.67M | 16.60M |
| Pretax profit | -4.00M | -92.00M | -116.00M | -3.00M | -31.52M | -129.16M | -35.94M | -24.11M |
| Tax | -15.00M | -15.00M | -38.00M | 8.00M | 2.66M | -3.86M | -4.67M | -831.00K |
| Net profit | 11.00M | -77.00M | -78.00M | -11.00M | -34.17M | -125.29M | -31.27M | -23.28M |
| Basic EPS | 0 | -2 | -2 | 0 | -1 | -2 | -1 | 0 |
| Diluted EPS | 0.10 | -1.51 | -2.00 | -0.21 | -0.64 | -2.03 | -0.50 | -0.37 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 47.21M | 312.44M | 311.54M | 61.30M | 72.01M | 305.12M |
| Gross profit | -3.96M | 98.00M | 97.15M | 29.95M | 11.13M | 48.52M |
| Selling & admin expenses | 27.24M | 34.94M | 34.75M | 31.98M | 35.26M | 43.56M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -44.45M | 41.79M | 38.93M | -19.66M | -41.25M | -18.54M |
| Pretax profit | -53.90M | 41.78M | 41.81M | -53.80M | -50.62M | -13.31M |
| Tax | -12.51M | 12.29M | 11.70M | -12.31M | -10.19M | -1.24M |
| Net profit | -41.39M | 29.49M | 30.10M | -41.49M | -40.43M | -12.06M |
| Basic EPS | -1 | 0 | 0 | -1 | -1 | 0 |
| Diluted EPS | -0.66 | 0.46 | 0.47 | -0.66 | -0.63 | -0.19 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 257.00M | 267.00M | 244.00M | 330.00M | 267.38M | 218.02M | 179.15M | 158.71M |
| Cash & ST investments | 107.00M | 142.00M | 151.00M | 142.00M | 150.66M | 125.15M | 110.14M | 99.88M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.81B | 1.59B | 1.57B | 1.64B | 1.49B | 1.50B | 1.52B | 1.61B |
| Total current liabilities | 84.00M | 188.00M | 173.00M | 136.00M | 240.91M | 233.67M | 286.66M | 377.04M |
| Short-term debt | 14.00M | 59.00M | 59.00M | 12.00M | 74.81M | 42.15M | 104.19M | 215.35M |
| Long-term debt | 477.00M | 495.00M | 611.00M | 685.00M | 467.16M | 527.12M | 512.93M | 523.28M |
| Total liabilities | 1,367,000,000.00 | 1,215,000,000.00 | 1,280,000,000.00 | 1,340,000,000.00 | 1,191,151,000.00 | 963,688,000.00 | 987,622,000.00 | 1,076,775,000.00 |
| Total equity | 438.00M | 378.00M | 291.00M | 296.00M | 299.51M | 540.64M | 536.22M | 538.18M |
| Retained earnings | -- | -- | -- | -- | -429.08M | -554.38M | -585.64M | -609.01M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 321.36M | 236.53M | 217.08M | 158.71M | 224.64M | 287.88M |
| Cash & ST investments | 244.68M | 96.20M | 82.24M | 99.88M | 135.20M | 116.28M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.68B | 1.68B | 1.67B | 1.61B | 1.69B | 1.74B |
| Total current liabilities | 413.87M | 371.16M | 249.70M | 377.04M | 490.88M | 585.91M |
| Short-term debt | 104.34M | 104.45M | 104.83M | 215.35M | 215.75M | 333.24M |
| Long-term debt | 595.12M | 598.66M | 655.09M | 523.28M | 493.43M | 459.89M |
| Total liabilities | 1,183,273,000.00 | 1,148,988,000.00 | 1,099,007,000.00 | 1,076,775,000.00 | 1,156,104,000.00 | 1,213,745,000.00 |
| Total equity | 498.17M | 534.87M | 572.46M | 538.18M | 531.15M | 526.64M |
| Retained earnings | -627.04M | -597.54M | -567.56M | -609.01M | -649.49M | -661.73M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 103.00M | 75.00M | -55.00M | 62.00M | 53.35M | 1.63M | 16.63M | 25.24M |
| Depreciation & amortization | 76.00M | 71.00M | 69.00M | 72.00M | 71.70M | 70.98M | 62.83M | 75.63M |
| Free cash flow | 70.00M | -28.00M | -136.00M | 27.00M | 35.68M | -67.41M | -69.38M | -26.10M |
| Dividends paid | 0 | -- | 0 | 0 | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -- | -- | 0 | -- | -- | -- | -- |
| Ending cash balance | 190.00M | 212.00M | 185.00M | 244.00M | 172.81M | 137.72M | 112.60M | 111.58M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 95.77M | -8.13M | -88.82M | 26.41M | 62.48M | -64.13M |
| Depreciation & amortization | 13.26M | 21.27M | 23.47M | 17.64M | 17.13M | 23.51M |
| Free cash flow | 76.25M | -25.01M | -96.38M | 19.04M | 53.85M | -71.37M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 266.99M | 153.62M | 114.62M | 111.58M | 168.86M | 178.96M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 1.16 | -18.69 | -23.32 | -3.75 | -11.86 | -30.46 | -5.94 | -4.45 |
| ROA %i | 0.27 | -4.53 | -4.93 | -0.69 | -2.25 | -8.41 | -2.07 | -1.49 |
| ROIC %i | 2.64 | -5.82 | -6.39 | 0.67 | -1.32 | -8.71 | 0.20 | 1.65 |
| 5-year avg ROE %i | -- | -- | -10.98 | -10.17 | -11.21 | -17.50 | -14.95 | -11.18 |
| EBIT margin %i | 4.98 | -13.66 | -50.56 | 3.70 | 0.34 | -14.28 | 0.43 | 3.05 |
| FCF / sales %i | 15.84 | -- | -- | 4.75 | 5.95 | -- | -- | -- |
| Current ratioi | 3.06 | 1.42 | 1.41 | 2.43 | 1.11 | 0.93 | 0.62 | 0.42 |
| Quick ratioi | 1.52 | 0.90 | 1.05 | 1.34 | 0.92 | 0.80 | 0.56 | 0.35 |
| Debt / assetsi | 27.20 | 34.78 | 42.65 | 42.60 | 43.55 | 44.73 | 47.31 | 51.84 |
| LT debt / equityi | 106.95 | 130.95 | 209.97 | 231.42 | 191.77 | 119.32 | 117.66 | 118.21 |
| Interest coveragei | 0.85 | -2.41 | -3.46 | 0.88 | 0.07 | -2.43 | 0.07 | 0.48 |
| Revenue CAGR (3Y) %i | -- | 22.02 | -22.74 | 8.72 | 7.33 | 53.25 | 5.28 | 7.56 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -27.21 | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -4.43 | -4.06 | -0.19 | -4.45 | -4.47 | -12.38 |
| ROA %i | -1.30 | -1.29 | -0.06 | -1.49 | -1.33 | -3.75 |
| ROIC %i | 0.27 | 1.39 | 2.52 | 1.65 | 0.45 | -1.79 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 0.78 | 2.71 | 7.41 | 3.05 | 3.49 | -3.83 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.78 | 0.64 | 0.87 | 0.42 | 0.46 | 0.49 |
| Quick ratioi | 0.66 | 0.42 | 0.68 | 0.35 | 0.34 | 0.35 |
| Debt / assetsi | 47.78 | 47.74 | 51.56 | 51.84 | 47.95 | 51.13 |
| LT debt / equityi | 143.79 | 133.79 | 135.10 | 118.21 | 114.32 | 108.23 |
| Interest coveragei | 0.13 | 0.46 | 1.21 | 0.48 | 0.56 | -0.61 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Baseball is the largest reported line at 90.60% of revenue, across 2 reported segments.
- The next-largest line, Mixed-Use Development, is a distant second at 9.40% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Baseball90.60%
Mixed-Use Development9.40%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.